Increasing life expectancy in cystic fibrosis: Advances and challenges
- PMID: 34672432
- PMCID: PMC9004282
- DOI: 10.1002/ppul.25733
Increasing life expectancy in cystic fibrosis: Advances and challenges
Abstract
Since the first description of cystic fibrosis in 1938, there have been significant advances in both quality of life and longevity for people living with this disease. In this article we describe the milestones of the last 80 years and what we perceive to be the remaining barriers to normalcy for this population.
Keywords: CFTR modulators; cystic fibrosis; lung function; survival.
© 2021 Wiley Periodicals LLC.
References
-
- Cystic Fibrosis Foundation Patient Registry. 2019 Annual Data Report. Bethesda, Maryland. ©2020 Cystic Fibrosis Foundation.
-
- Andersen DH. Cystic fibrosis of the pancreas and it’s relation to celiac disease. Am J Dis Child 1938;56(2):344.
-
- Di Sant’Agnese P, Darling R, Perera B, Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease. Pediatrics 1953;12(5):549–563. - PubMed
-
- Matthews LW, Doershuk CF, Wise M, Eddy G, Nudelman H, Spector S. A therapeutic regimen for patients with cystic fibrosis. J Pediatr 1964;65(4):558–575. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
